Sovran Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Buy
12,511
+814
+7% +$190K 0.25% 113
2026
Q1
$2.69M Buy
11,697
+2,458
+27% +$573K 0.21% 119
2025
Q4
$2.03M Buy
9,239
+976
+12% +$193K 0.17% 132
2025
Q3
$1.56M Buy
8,263
+1,940
+31% +$332K 0.14% 160
2025
Q2
$985K Buy
6,323
+422
+7% +$64.9K 0.1% 207
2025
Q1
$929K Sell
5,901
-16,814
-74% -$2.63M 0.12% 179
2024
Q4
$3.29M Buy
+22,715
New +$3.52M 0.47% 53

Other funds holding JNJ

Sovran Advisors's JNJ Position: Q2 2026 in Review

Sovran Advisors increased its Johnson & Johnson (JNJ) stake by 7% in Q2 2026, buying an estimated $190K and bringing the position to 12,511 shares worth $3.34M. The position accounts for 0.25% of the portfolio, ranked #113.

Sovran Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sovran Advisors held 12,511 shares of Johnson & Johnson worth $3.34M as of Q2 2026.
  • Sovran Advisors bought 814 Johnson & Johnson shares in Q2 2026, an estimated $190K.
  • Johnson & Johnson made up 0.25% of Sovran Advisors's portfolio in Q2 2026, its #113 holding.
  • Sovran Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.